Carl Zeiss Meditec (ETR:AFX) has been given a €60.00 ($71.43) target price by research analysts at Nord/LB in a report released on Tuesday. The firm currently has a “buy” rating on the stock. Nord/LB’s price objective would indicate a potential upside of 14.26% from the stock’s previous close.

AFX has been the topic of a number of other reports. Independent Research set a €54.00 ($64.29) target price on shares of Carl Zeiss Meditec and gave the company a “neutral” rating in a research note on Friday. Commerzbank set a €42.00 ($50.00) price target on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research report on Friday. Berenberg Bank set a €48.00 ($57.14) price target on shares of Carl Zeiss Meditec and gave the stock a “buy” rating in a research report on Friday. Deutsche Bank set a €40.00 ($47.62) price objective on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Friday, December 1st. Finally, set a €52.00 ($61.90) price target on shares of Carl Zeiss Meditec and gave the company a “buy” rating in a report on Friday, November 10th. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of €49.21 ($58.59).

Carl Zeiss Meditec (ETR:AFX) opened at €52.51 ($62.51) on Tuesday. Carl Zeiss Meditec has a 1-year low of €31.44 ($37.43) and a 1-year high of €52.83 ($62.89).

ILLEGAL ACTIVITY WARNING: “Carl Zeiss Meditec (AFX) PT Set at €60.00 by Nord/LB” was posted by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/12/12/carl-zeiss-meditec-afx-pt-set-at-60-00-by-nordlb.html.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related companies with MarketBeat.com's FREE daily email newsletter.